P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
EXEL | 29.0 | 23.1 | 0.2 | +102.37% |
EXEL Peer | 16.5 | 21.5 | 0.1 | +202.13% |
Biotechnology Industry | 17.7 | 16.0 | 0.3 | +56.35% |
Health Technology Sector | 32.4 | 21.0 | 0.5 | +23.02% |
S&P 500 Market | 31.0 | 26.2 | 1.1 | +97.60% |
Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
---|---|---|---|---|
Mean Estimate | $0.22 | $0.23 | $0.24 | $0.23 |
Previous Mean | N/A | $0.23 | $0.24 | N/A |
Standard Deviation | 0.03 | 0.03 | 0.08 | 0.04 |
Low Estimate | $0.16 | $0.17 | $0.11 | $0.20 |
High Estimate | $0.26 | $0.28 | $0.45 | $0.27 |